| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling
|
Li, Rui
|
|
2014
|
41 |
3 |
p. 197-209
|
article
|
| 2 |
Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7
|
Johansson, Åsa M.
|
|
2014
|
41 |
3 |
p. 223-238
|
article
|
| 3 |
Evaluation of sampling spacing in pharmacokinetic studies using six sigma method
|
Grabowski, Tomasz
|
|
2014
|
41 |
3 |
p. 251-260
|
article
|
| 4 |
Information contributed by meta-analysis in exposure–response modeling: application to phase 2 dose selection of guselkumab in patients with moderate-to-severe psoriasis
|
Hu, Chuanpu
|
|
2014
|
41 |
3 |
p. 239-250
|
article
|
| 5 |
Methods to detect non-compliance and reduce its impact on population PK parameter estimates
|
Gibiansky, Leonid
|
|
2014
|
41 |
3 |
p. 279-289
|
article
|
| 6 |
Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator
|
Krause, Andreas
|
|
2014
|
41 |
3 |
p. 261-278
|
article
|
| 7 |
Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients
|
Owens, Katie H.
|
|
2014
|
41 |
3 |
p. 211-221
|
article
|
Journal description